Intersect ENT, Inc. - Common Stock (NQ:XENT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 12, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Intersect ENT, Inc. - Common Stock

< Previous 1 2 Next >

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

January 25, 2022

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT Reports Third Quarter 2021 Financial Results

November 02, 2021

From Intersect ENT, Inc.

Via Business Wire

First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

October 28, 2021

From Intersect ENT®, Inc.

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm

September 13, 2021

NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ: INOV)...

From Halper Sadeh LLP

Via AccessWire

Topics Fraud

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, GTS, XONE, XENT; Shareholders are Encouraged to Contact the Firm

September 04, 2021

NEW YORK, NY / ACCESSWIRE / September 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ:INOV)...

From Halper Sadeh LLP

Via AccessWire

Topics Fraud

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, XENT, FFWM, RIVE; Shareholders are Encouraged to Contact the Firm

August 19, 2021

NEW YORK, NY / ACCESSWIRE / August 19, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cornerstone OnDemand, Inc. (NASDAQ:CSOD)...

From Halper Sadeh LLP

Via AccessWire

Topics Fraud

INVESTIGATION: Halper Sadeh LLP Investigates NLOK, XENT, NWHM; Shareholders are Encouraged to Contact the Firm

August 12, 2021

NEW YORK, NY / ACCESSWIRE / August 12, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: NortonLifeLock Inc. (NASDAQ:NLOK) concerning...

From Halper Sadeh LLP

Via AccessWire

Topics Fraud

Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021 ↗

August 12, 2021

Upgrades According to Northland Capital Markets, the prior rating for Points International Ltd

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021 ↗

August 09, 2021

Upgrades DA Davidson upgraded the previous rating for AAON Inc (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

INTERSECT ENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intersect ENT - XENT

August 06, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

Why Intersect ENT Shot 12% Higher on Friday ↗

August 06, 2021

It's official: A big peer is buying out the specialty medical device maker.

Via The Motley Fool

Intersect ENT Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Intersect ENT, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – XENT

August 06, 2021

From Halper Sadeh LLP

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 06, 2021

Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 20.59% to $3.08 during Friday's regular session. The current volume of 16.2 million shares is 348.19% of SCWorx...

Via Benzinga

Medtronic Expands Its ENT Portfolio With Intersect ENT Acquisition For $28.25/Share ↗

August 06, 2021

Medtronic plc (NYSE:MDT)

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 06, 2021

Gainers Applied Molecular (NASDAQ:AMTI) shares increased by 19.38% to $35.54 during Friday's pre-market session. The market value of their outstanding shares is at $1....

Via Benzinga

Intersect ENT: Q2 Earnings Insights ↗

August 06, 2021

Shares of Intersect ENT (NASDAQ:XENT) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 24.62% year over year to ($0...

Via Benzinga

Intersect ENT Reports Second Quarter 2021 Financial Results

August 06, 2021

From Intersect ENT, Inc.

Via Business Wire

U.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis

July 26, 2021

From Intersect ENT

Via Business Wire

Earnings Scheduled For August 6, 2021 ↗

August 06, 2021

Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million....

Via Benzinga

Intersect ENT Sees Q2 Sales Lag Wall Street Estimates; Raises $60M In Debt Funding ↗

July 23, 2021

Intersect ENT Inc (NASDAQ: XENT) expects Q2 sales of approximately $27.3 million, slightly below the consensus estimate of $28.02 million. Record quarterly revenue from...

Via Benzinga

Intersect ENT to Report Second Quarter 2021 Financial Results on August 6

July 23, 2021

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan

July 22, 2021

From Intersect ENT, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021 ↗

June 24, 2021

Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE:

Via Benzinga

Intersect ENT Insights: Return On Capital Employed ↗

June 23, 2021

In Q1, Intersect ENT (NASDAQ:XENT) posted sales of $24.33 million. Earnings were up 7.66%, but Intersect ENT still reported an overall loss of $18.57 million. Intersect ENT...

Via Benzinga

Intersect ENT Insights: Return On Capital Employed ↗

June 07, 2021

In Q1, Intersect ENT (NASDAQ:XENT) posted sales of $24.33 million. Earnings were up 7.66%, but Intersect ENT still reported an overall loss of $18.57 million. In Q4, Intersect ENT...

Via Benzinga

Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery

May 20, 2021

From Intersect ENT, Inc.

Via Business Wire

Recap: Intersect ENT Q1 Earnings ↗

May 10, 2021

Shares of Intersect ENT (NASDAQ:XENT) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share rose 5.56% year over year to ($0.51),...

Via Benzinga

Intersect ENT Reports First Quarter 2021 Financial Results

May 10, 2021

From Intersect ENT, Inc.

Via Business Wire

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.